Companies: 10,795·Total market cap: $144.5T
Biotest AG

Biotest AG

BTTAYOTCHealthcare
$24.23
+$0.00(+0.00%)
Market Cap$943029783
P/E Ratio
52W High$24.27
52W Low$22.8

Biotest AG(BTTAY)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · BTTAY · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2024-122023-122022-122021-122020-12
Revenue
Revenue$0.73B$0.68B$0.52B$0.52B$0.48B
Cost of Revenue$0.50B$0.40B$0.39B$0.43B$0.35B
Gross Profit$0.22B$0.28B$0.12B$0.08B$0.13B
Gross Margin %(computed)30.82%40.94%24.20%15.65%26.87%
Operating Expenses
R&D Expenses$0.06B$0.07B$0.05B$0.05B$0.06B
G&A Expenses$0.04B$0.03B$0.03B$0.03B$0.03B
Total Operating Expenses$0.13B$0.14B$0.13B$0.13B$0.13B
Operating Income$0.09B$0.14B($0.02B)($0.05B)($0.00B)
Operating Margin %(computed)13.01%20.96%-3.22%-9.13%-0.27%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.03B$0.04B$0.02B$0.01B$0.01B
Income Before Tax$0.05B$0.11B($0.03B)($0.06B)($0.03B)
Income Tax Expense$0.02B($0.02B)$0.00B$0.00B$0.00B
Net Income$0.03B$0.13B($0.03B)($0.06B)($0.03B)
Net Margin %(computed)3.64%18.55%-6.12%-12.28%-6.48%
Per Share & EBITDA
EPS (Basic)$0.36$1.60$-0.40$-0.80$-0.39
Wtd Avg Shares0.07B0.08B0.08B0.08B0.08B
EBITDA$0.12B$0.18B$0.02B($0.02B)$0.01B
EBITDA Margin %(computed)16.58%26.61%4.79%-3.55%2.85%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · EUR · B

深入了解Biotest AG

关于Biotest AG(BTTAY)损益表

Biotest AG(BTTAY)损益表数据来源于SEC Form 10-K及10-Q申报文件。2024财年,BTTAY实现营收$0.73B,毛利润$0.22B(毛利率30.82%),净利润$0.03B(净利率3.64%)。

常见问题

BTTAY · 4 问

Biotest AG(BTTAY)2024财年营收为$0.73B,同比up6.1%。

BTTAY revenueBTTAY salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08